Company Email Format Management

Solvonis Therapeutics (formerly Awakn)

Biotechnology Research London, City of, United Kingdom 5 employees CNS

Employees: 5

awaknlifesciences.com LinkedIn Crunchbase

Solvonis Therapeutics (formerly Awakn) Overview

Headquarters: London, City of, United Kingdom
Phone Number: Available in AeroLeads
Website: awaknlifesciences.com
Industry: Biotechnology Research
Employees: 5
Founded: 2020
Stock Symbol: CNS
Funding: 535.0K
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology Clinical Stage Alcohol Use Disorder Addiction

About Solvonis Therapeutics (formerly Awakn)

Solvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing innovative medicines for addiction and mental health disorders. Headquartered in London and listed on the London Stock Exchange main market, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need. The company’s current focus is on Alcohol Use Disorder (AUD)—affecting over 40 million people across the U.S., UK, and EU4—and Post-Traumatic Stress Disorder (PTSD), which impacts more than 13 million adults in the U.S. and approximately 20 million across the same regions.

Solvonis Therapeutics (formerly Awakn) Contact Details

People in AeroLeads: 3

Solvonis Therapeutics (formerly Awakn) Org Chart

Sample employees and titles

Name	Title	Location	Contact
Owain Winfield	Head of Psychological Services at Awakn	Greater Exeter Area, United Kingdom	View
Leo Milner	Registered Mental Health Nurse at Awakn	United Kingdom	View
Verity Howard	Registered Mental Health Nurse at Awakn	Bristol, England, United Kingdom	View